Similarly, poly-(β-amino ester) nanoparticle delivery of a stimulator of interferon genes (STING) signaling agonist (ADU S-100), when administered together with a PD-1 blocking antibody, resulted in a >10-fold improvement of anti-tumor effects in a B16 melanoma model [28]. Here, PDCD1 is linked to melanoma.